Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Chembio, FIND to Develop POC Test for Febrile Illnesses Common in Asia-Pacific

Chembio, FIND to Develop POC Test for Febrile Illnesses Common in Asia-Pacific

Apr 04, 2017
|
staff reporter

NEW YORK (360Dx) – Chembio Diagnostics today announced a collaboration with FIND to develop a point-of-care test aimed at identifying multiple life-threatening acute febrile illnesses common in the Asia-Pacific region.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Infectious Disease

  1. Roche SARS-CoV-2 Lateral Flow Antigen Test Could Meet Significant Demand

    Premium

  2. Commercial Coronavirus Antibody Tests Show Wide Variation in Accuracy in New Study

  3. Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

  4. FDA Authorizes First COVID-19 Serology Test for Point-of-Care Use

  5. Oxford Immunotec T-Cell Test for SARS-CoV-2 Being Evaluated in Public Health England Study

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.